StonvexLoading…
StonvexCore line items from HSDT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-12 | Annual 2025 2025-12-31 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|---|
Revenue | $2.96M | $548.00K | $71.00K | $38.00K | $520.00K |
Operating Income | Not available | $-243.84M | $-7.33M | $-4.01M | $-13.90M |
Net Income | Not available | $-40.89M | $-13.67M | $-3.84M | $-11.74M |
EPS (Diluted) | $-0.07 | $-1.85 | $-201.55 | $-382.29 | $-3282.26 |
Total Assets | Not available | $303.93M | $7.89M | $3.48M | $3.54M |
Total Liabilities | Not available | $3.02M | $1.87M | $2.20M | $2.48M |
Cash & Equivalents | Not available | $7.28M | $6.08M | $1.11M | $1.09M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available | $-11.05M |
Shares Outstanding | Not available | 43.74M | 680.48K | 6.13M | 4.94K |